Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Sectors

Corporates help eGenesis generate $125m

Xenotransplantation technology developer eGenesis took its total funding to $263m in a series C round backed by Bayer and Fresenius Medical Care.


Mar 3, 2021

FogPharma finds $107m in series C

GV returned for a series C round that helped the precision cancer medicine developer increase its overall funding to over $180m.

Mar 3, 2021

Olympus eyes Medi-Tate acquisition

Laborie is set to exit the medical device manufacturer after another of its investors, Olympus, announced its intention to pay $260m for its remaining shares.

Mar 3, 2021

ACV Auctions aims for $100m in IPO

Online car dealership service ACV Auctions has filed to go public having previously raised some $360m in funding from investors including SoftBank.

Mar 3, 2021

Artizan crafts $11m series A2

Osage University Partners has thrown its weight behind a series A2 round for Artizan, which is advancing work undertaken at Yale University.

Mar 3, 2021

Artizan crafts $11m series A2 round

Biohaven Therapeutics co-led Artizan Biosciences' latest round as part of an option and licensing agreement focusing on its inflammatory bowel disease drug candidates.

Mar 3, 2021

Osage helps orchestrate eGenesis series C

Xenotransplantation technology developer eGenesis has raised $125m in a series C round backed by Osage University Partners.

Mar 3, 2021

Genomics gets its hands on $30m

The Vertex Pharmaceuticals-backed genomic analytics platform developer has now raised approximately $88m in funding altogether.

Mar 3, 2021

Investors bet on Rivalry in $20m round

An unnamed casino operator invested in the sports and esports betting platform developer in around that will support international expansion.

Mar 2, 2021

ClickPaas adds series B funding

The low-code app app development software provider's eight-figure round included BAI and SIG Asia.

Mar 2, 2021

Reliance levitates to SkyTran acquisition

Reliance paid $26.8m to gain majority control of the passive magnetic levitation and propulsion technology developer and now owns 54.5% of its shares.

Mar 2, 2021

Gitai gets series B cash

Seiko Epson’s EP-GB fund and Dai-ichi Life helped provide $17.1m for Gitai as it prepares a demonstration of its space robotics technology.

Mar 2, 2021
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here